@prefix dcterms: . @prefix this: . @prefix sub: . @prefix beldoc: . @prefix rdfs: . @prefix rdf: . @prefix xsd: . @prefix dce: . @prefix pav: . @prefix np: . @prefix belv: . @prefix prov: . @prefix schem: . @prefix RNA: . @prefix hgnc: . @prefix geneProductOf: . @prefix obo: . @prefix occursIn: . @prefix species: . @prefix pubmed: . @prefix orcid: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { sub:_1 geneProductOf: hgnc:10045; a RNA: . sub:_2 occursIn: obo:CLO_0009348, species:9606; rdf:object sub:_1; rdf:predicate belv:decreases; rdf:subject schem:Oxidized%20Low%20Density%20Lipoprotein; a rdf:Statement . sub:assertion rdfs:label "a(SCHEM:\"Oxidized Low Density Lipoprotein\") -| r(HGNC:RNASE2)" . } sub:provenance { beldoc: dce:description "Approximately 61,000 statements."; dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved."; dce:title "BEL Framework Large Corpus Document"; pav:authoredBy sub:_4; pav:version "20131211" . sub:_3 prov:value "Differentiation of human THP-1 cells into foam cells on treatment with 12-O-tetradecanoylphorbol 13-acetate (PMA) was observed in atherosclerotic lesions. When these THP-1 differentiated cells were subsequently treated with oxidized low density lipoprotein (Ox-LDL), it was observed that RNASE2 (ribonuclease, RNase A family, 2) expressed low. At the end of fourth day of treatment with Ox-LDL the expression of RNASE2 was decreased by 5.33-folds when compared with control. This indicates that Ox-LDL down-regulates RNASE2 in differentiated THP-1cells."; prov:wasQuotedFrom pubmed:10973959 . sub:_4 rdfs:label "Selventa" . sub:assertion prov:hadPrimarySource pubmed:10973959; prov:wasDerivedFrom beldoc:, sub:_3 . } sub:pubinfo { this: dcterms:created "2014-07-03T14:31:37.074+02:00"^^xsd:dateTime; pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 . }